158 related articles for article (PubMed ID: 33243106)
1. Recent Advances in Elucidating Paclitaxel Resistance Mechanisms in Non-small Cell Lung Cancer and Strategies to Overcome Drug Resistance.
Cui H; Arnst K; Miller DD; Li W
Curr Med Chem; 2020; 27(39):6573-6595. PubMed ID: 33243106
[TBL] [Abstract][Full Text] [Related]
2. Potential monoamine oxidase A inhibitor suppressing paclitaxel-resistant non-small cell lung cancer metastasis and growth.
Yang X; Zhao D; Li Y; Li Y; Cui W; Li Y; Li H; Li X; Wang D
Thorac Cancer; 2020 Oct; 11(10):2858-2866. PubMed ID: 32875729
[TBL] [Abstract][Full Text] [Related]
3. Combination of Paclitaxel and PXR Antagonist SPA70 Reverses Paclitaxel-Resistant Non-Small Cell Lung Cancer.
Niu X; Wu T; Yin Q; Gu X; Li G; Zhou C; Ma M; Su L; Tang S; Tian Y; Yang M; Cui H
Cells; 2022 Oct; 11(19):. PubMed ID: 36231056
[TBL] [Abstract][Full Text] [Related]
4. Sulforaphane metabolites reduce resistance to paclitaxel via microtubule disruption.
Wang Y; Zhou Y; Zheng Z; Li J; Yan Y; Wu W
Cell Death Dis; 2018 Nov; 9(11):1134. PubMed ID: 30429459
[TBL] [Abstract][Full Text] [Related]
5. An EHMT2/NFYA-ALDH2 signaling axis modulates the RAF pathway to regulate paclitaxel resistance in lung cancer.
Wang W; Wang J; Liu S; Ren Y; Wang J; Liu S; Cui W; Jia L; Tang X; Yang J; Wu C; Wang L
Mol Cancer; 2022 Apr; 21(1):106. PubMed ID: 35477569
[TBL] [Abstract][Full Text] [Related]
6. SOX2 regulates paclitaxel resistance of A549 non‑small cell lung cancer cells via promoting transcription of ClC‑3.
Huang Y; Wang X; Hu R; Pan G; Lin X
Oncol Rep; 2022 Oct; 48(4):. PubMed ID: 36069232
[TBL] [Abstract][Full Text] [Related]
7. Overcoming drug-resistant lung cancer by paclitaxel loaded tetrahedral DNA nanostructures.
Xie X; Shao X; Ma W; Zhao D; Shi S; Li Q; Lin Y
Nanoscale; 2018 Mar; 10(12):5457-5465. PubMed ID: 29484330
[TBL] [Abstract][Full Text] [Related]
8. p38 MAPK-induced MDM2 degradation confers paclitaxel resistance through p53-mediated regulation of EGFR in human lung cancer cells.
Park SH; Seong MA; Lee HY
Oncotarget; 2016 Feb; 7(7):8184-99. PubMed ID: 26799187
[TBL] [Abstract][Full Text] [Related]
9. Enhanced antitumor efficacy by paclitaxel-loaded pluronic P123/F127 mixed micelles against non-small cell lung cancer based on passive tumor targeting and modulation of drug resistance.
Zhang W; Shi Y; Chen Y; Yu S; Hao J; Luo J; Sha X; Fang X
Eur J Pharm Biopharm; 2010 Aug; 75(3):341-53. PubMed ID: 20451605
[TBL] [Abstract][Full Text] [Related]
10. Metformin Suppresses Stemness of Non-Small-Cell Lung Cancer Induced by Paclitaxel through FOXO3a.
Tang Z; Zhang Y; Yu Z; Luo Z
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38068934
[TBL] [Abstract][Full Text] [Related]
11. Nuclear complement C3b promotes paclitaxel resistance by assembling the SIN3A/HDAC1/2 complex in non-small cell lung cancer.
Wang X; Hao Y; Chen J; Ding P; Lv X; Zhou D; Li L; Li L; Xu Y; Zhu Y; Zhang W; Chen L; Liao T; He X; Ji QH; Hu W
Cell Death Dis; 2023 Jun; 14(6):351. PubMed ID: 37291119
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-22 (IL-22) Regulates Apoptosis of Paclitaxel-Resistant Non-Small Cell Lung Cancer Cells Through C-Jun N-Terminal Kinase Signaling Pathway.
Li C; Zhao X; Yang Y; Liu S; Liu Y; Li X
Med Sci Monit; 2018 May; 24():2750-2757. PubMed ID: 29723165
[TBL] [Abstract][Full Text] [Related]
13. Synergistic Anticancer Activity of Combined Use of Caffeic Acid with Paclitaxel Enhances Apoptosis of Non-Small-Cell Lung Cancer H1299 Cells in Vivo and in Vitro.
Min J; Shen H; Xi W; Wang Q; Yin L; Zhang Y; Yu Y; Yang Q; Wang ZN
Cell Physiol Biochem; 2018; 48(4):1433-1442. PubMed ID: 30064123
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of non-homologous end joining mitigates paclitaxel resistance resulting from mitotic slippage in non-small cell lung cancer.
Tsuji K; Kikuchi E; Takashima Y; Shoji T; Takahashi H; Ito S; Morinaga D; Kashima M; Maeda M; Kitai H; Kikuchi J; Sakakibara-Konishi J; Konno S
Cell Cycle; 2023 Sep; 22(17):1854-1864. PubMed ID: 37592765
[TBL] [Abstract][Full Text] [Related]
15. Potential of the dual mTOR kinase inhibitor AZD2014 to overcome paclitaxel resistance in anaplastic thyroid carcinoma.
Milošević Z; Banković J; Dinić J; Tsimplouli C; Sereti E; Dragoj M; Paunović V; Milovanović Z; Stepanović M; Tanić N; Dimas K; Pešić M
Cell Oncol (Dordr); 2018 Aug; 41(4):409-426. PubMed ID: 29790111
[TBL] [Abstract][Full Text] [Related]
16. Emodin enhances antitumor effect of paclitaxel on human non-small-cell lung cancer cells in vitro and in vivo.
Chen S; Zhang Z; Zhang J
Drug Des Devel Ther; 2019; 13():1145-1153. PubMed ID: 31114158
[No Abstract] [Full Text] [Related]
17. Paclitaxel nanosuspension coated with P-gp inhibitory surfactants: II. Ability to reverse the drug-resistance of H460 human lung cancer cells.
Gao L; Liu G; Ma J; Wang X; Wang F; Wang H; Sun J
Colloids Surf B Biointerfaces; 2014 May; 117():122-7. PubMed ID: 24632038
[TBL] [Abstract][Full Text] [Related]
18. [Tumor growth inhibition of paclitaxel-octreotide conjugates on human non small cell lung cancer: experiment with mice].
Shen HC; Wang XW; Liu YG
Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(35):2498-503. PubMed ID: 19080633
[TBL] [Abstract][Full Text] [Related]
19. The Superior Antitumor Effect of Self-Assembled Paclitaxel Nanofilaments for Lung Cancer Cells.
He M; Zhu J; Yu N; Kong H; Zeng X; Xie W; Xu H
Curr Drug Deliv; 2019; 16(2):171-178. PubMed ID: 30332958
[TBL] [Abstract][Full Text] [Related]
20. Re-expression of LKB1 in LKB1-mutant EKVX cells leads to resistance to paclitaxel through the up-regulation of MDR1 expression.
Mao K; Liu F; Liu X; Khuri FR; Marcus AI; Li M; Zhou W
Lung Cancer; 2015 May; 88(2):131-8. PubMed ID: 25769882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]